Cargando…
Targeting Hepatitis B Virus With CRISPR/Cas9
Hepatitis B virus persistence in infected hepatocytes is due to the presence of covalently closed circular DNA (cccDNA), the template for the transcription of viral RNAs. Antiviral therapies with nucleoside analogues inhibit replication of HBV DNA in capsids present in the cytoplasm of infected cell...
Autores principales: | Seeger, Christoph, Sohn, Ji A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272409/ https://www.ncbi.nlm.nih.gov/pubmed/25514649 http://dx.doi.org/10.1038/mtna.2014.68 |
Ejemplares similares
-
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
por: Seeger, Christoph, et al.
Publicado: (2016) -
CRISPR/Cas9 for hepatitis B virus infection treatment
por: Cai, Bo, et al.
Publicado: (2023) -
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
por: Stone, Daniel, et al.
Publicado: (2020) -
Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
por: Li, Hao, et al.
Publicado: (2017) -
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
por: Ramanan, Vyas, et al.
Publicado: (2015)